MiMedx Group, Inc (MDXG) News
Filter MDXG News Items
MDXG News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
MDXG News Highlights
- MDXG's 30 day story count now stands at 2.
- Over the past 13 days, the trend for MDXG's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- DEC are the most mentioned tickers in articles about MDXG.
Latest MDXG News From Around the Web
Below are the latest news stories about MIMEDX GROUP INC that investors may wish to consider to help them evaluate MDXG as an investment opportunity.
MIMEDX Announces Conversion of Outstanding Series B Convertible Preferred Stock to Common StockMARIETTA, Ga., Dec. 28, 2023 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that its outstanding 95,000 shares of Series B Convertible Preferred Stock (the “Preferred Stock”), together with any accrued dividends, were automatically converted into shares of the Company’s Common Stock on December 22, 2023, in accordance with the Preferred Stock terms set forth in the Company’s Articles of Incorporation. As a result of this conversion, approximatel |
Is MiMedx Group, Inc. (NASDAQ:MDXG) Trading At A 50% Discount?Key Insights Using the 2 Stage Free Cash Flow to Equity, MiMedx Group fair value estimate is US$17.71 MiMedx Group's... |
MIMEDX to Participate in Upcoming Investor ConferencesMARIETTA, Ga., Nov. 13, 2023 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that members of its senior management will participate in the following investor conferences: Craig-Hallum Capital Group 14th Annual Alpha Select Conference Thursday, November 16, 2023Sheraton New York Times Square Hotel811 7th Avenue, W 53rd St New York, NY Mizuho Medical Device & Healthcare Services Summit 2023Wednesday, December 6, 2023Sofitel New York45 W 44th StNew |
MIMEDX to Highlight Published Data at SAWC FallCompany Will Sponsor Lunch Symposium on November 3, 2023MARIETTA, Ga., Nov. 02, 2023 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced it will sponsor an Innovation Theater lunch symposium at the Symposium on Advanced Wound Care (SAWC) Fall meeting taking place November 2-5 in Las Vegas, NV. In addition, the Company will participate in the conference’s exhibition at booth number 511. In the session, Drs. Mouawad, Tettelbach, and Wahab will review r |
Loss-Making MiMedx Group, Inc. (NASDAQ:MDXG) Set To BreakevenMiMedx Group, Inc. ( NASDAQ:MDXG ) is possibly approaching a major achievement in its business, so we would like to... |
MiMedx Group, Inc. (NASDAQ:MDXG) Q3 2023 Earnings Call TranscriptMiMedx Group, Inc. (NASDAQ:MDXG) Q3 2023 Earnings Call Transcript October 30, 2023 MiMedx Group, Inc. beats earnings expectations. Reported EPS is $0.06, expectations were $0.04. Operator: Good afternoon, and thank you for standing by. Welcome to the MiMedx Third Quarter ‘23 Operating and Financial Results Conference Call. At this time, all participants are in a […] |
Q3 2023 MiMedx Group Inc Earnings CallQ3 2023 MiMedx Group Inc Earnings Call |
MDXG: Xenografts and Synthetics Options for ExpansionBy John Vandermosten, CFA NASDAQ:MDXG READ THE FULL MDXG RESEARCH REPORT Third Quarter 2023 Summary MiMedx Group, Inc. (NASDAQ:MDXG) reported third quarter 2023 revenues of $81.7 million, representing a 21% year over year growth rate, surpassing our $76.4 million estimate. Net income was $8.5 million, benefitting from lower expenses on every line. Management firmed up revenue growth guidance for |
MiMedx Group Inc (MDXG) Reports 20.7% Increase in Q3 2023 Net SalesCompany Raises Full-Year 2023 Net Sales Percentage Growth Outlook to High Teens |
MIMEDX Announces Third Quarter 2023 Operating and Financial ResultsThird Consecutive Quarter of Net Sales Growth Exceeding 20% Over the Prior Year Period Raises Full-Year 2023 Net Sales Percentage Growth Outlook to the High Teens MARIETTA, Ga., Oct. 30, 2023 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), today announced operating and financial results for the quarter ended September 30, 2023. Recent Operating and Financial Highlights: Third quarter 2023 net sales of $81.7 million, an increase of 20.7% over third quarter 2022. |